Treatment of Narcolepsy in Pregnancy

Managing narcolepsy in a patient who is pregnant or planning to conceive requires a fundamental reassessment of the treatment approach. Pharmacotherapy decisions, symptom control strategies, and the involvement of obstetric care all shift in this setting.

Clinical Scenario

A patient with narcolepsy who is pregnant or planning to become pregnant. Collaboration with the patient's obstetrician is a central part of care in this context.

Approach Overview

The approach centres on reconsidering narcolepsy pharmacotherapy in relation to conception and pregnancy, and establishing nonpharmacologic strategies — including scheduled napping — to manage symptoms. The complete protocol specifies which agents, the relevant timing, and the full compensatory plan.

Clinical Goal

Residual sleepiness controlled through extended sleep time and structured, scheduled naps.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.9740/mhc.2025.12.258

When managing narcolepsy in a patient who is pregnant or plans to become pregnant, collaboration with the patient's obstetrician is essential.
When pregnancy is planned or desired, medications used for narcolepsy should be discontinued prior to conception whenever possible; the decision to continue pharmacotherapy while pursuing pregnancy should be an informed collaborative decision between the patient and pertinent health care providers.
In both situations, compensatory plans should be enacted, including scheduled napping.
Data on modafinil use and embryo or fetal harm is conflicting, and as a result, modafinil is often discontinued in pregnant patients during the first 10 weeks from the last menstrual period.
Scheduled napping helped with residual sleepiness.

View source ↗